Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 680

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 680
---
[Signature page to follow.]

A-95</div>

TABLE OF CONTENTS

IN WITNESS WHEREOF, this Seventh Amendment to Business Combination Agreement has been duly executed and delivered by each of the Parties as of the date first above written.

#### SPAC
Iris Acquisition Corp

By:

/s/ Sumit Mehta

Name:

Sumit Mehta

Title:

Chief Executive Officer

### COMPANY
Liminatus Pharma, LLC

By:

/s/ Chris Kim

Name:

Chris Kim

Title:

CEO, Secretary and Treasurer

### PARENTCO
Iris Parent Holding Corp.

By:

/s/ Chris Kim

Name:

Chris Kim

Title:

CEO, Secretary and Treasurer

<div align='center'>Signature Page to Seventh Amendment to Business Combination Agreement

A-96</div>

TABLE OF CONTENTS

#### Annex B​

#### LIMINATUS PHARMA, INC.

#### 2024 OMNIBUS EQUITY INCENTIVE PLAN
<div align='center'>B-1</div>

TABLE OF CONTENTS

#### LIMINATUS PHARMA, INC.

#### 2024 OMNIBUS EQUITY INCENTIVE PLAN

### ARTICLE IPURPOSE
The purpose of this Liminatus Pharma, Inc. 2024 Omnibus Equity Incentive Plan (the “ Plan ”) is to benefit Liminatus Pharma, Inc., a Delaware corporation (the “ Company ”) and its stockholders, by assisting the Company and its subsidiaries to attract, retain and provide incentives to key management employees, directors, and consultants of the Company and its Affiliates, and to align the interests of such service providers with those of the Company’s stockholders. Accordingly, the Plan provides for the granting of Non-qualified Stock Options, Incentive Stock Options, Restricted Stock Awards, Restricted Stock Unit Awards, Stock Appreciation Rights, Performance Stock Awards, Performance Unit Awards, Unrestricted Stock Awards, Distribution Equivalent Rights or any combination of the foregoing.

### ARTICLE IIDEFINITIONS
The following definitions shall be applicable throughout the Plan unless the context otherwise requires:

2.1 “ Affiliate ” shall mean any corporation which, with respect to the Company, is a “subsidiary corporation” within the meaning of Section 424(f) of the Code or other entity in which the Company has a controlling interest in such entity or another entity which is part of a chain of entities in which the Company or each entity has a controlling interest in another entity in the unbroken chain of